Interventional Cardiology & Peripheral Vascular Devices Market - By Product (Interventional Catheters, Guidewires, Stents, PTCA Balloons, Atherectomy Devices, Embolic Protection Devices), Application, End-use & Global Forecast to 2032

Report Content

Chapter 1   Methodology & Scope

1.1    Industry coverage

1.2    Market scope & definitions

1.3    Base estimates & working

1.3.1    North America

1.3.2    Europe

1.3.3    Asia Pacific

1.3.4    Latin America

1.3.5    MEA

1.4    Forecast parameters

1.5    COVID-19 impact analysis at global level

1.6    Data validation

1.7    Data sources

1.7.1    Primary

1.7.2    Secondary

1.7.2.1   Paid sources

1.7.2.2   Unpaid sources

Chapter 2   Executive Summary

2.1    Interventional cardiology & peripheral vascular devices industry 360⁰ synopsis, 2018 - 2032

2.1.1    Business trends

2.1.2    Product trends

2.1.3    Application trends

2.1.4    End-use trends

2.1.5    Regional trends

Chapter 3   Interventional Cardiology & Peripheral Vascular Devices Industry Insights

3.1    Industry landscape, 2018 – 2032

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1   Growing prevalence of vascular diseases worldwide

3.2.1.2   Technological advancements in peripheral vascular devices

3.2.1.3   Rising adoption of minimally invasive procedures

3.2.1.4   Increasing government spending pertaining to cardiovascular diseases burden

3.2.2    Industry pitfalls & challenges

3.2.2.1   Stringent regulatory framework

3.2.2.2   Post-procedural complications associated with devices

3.3    Growth potential analysis

3.3.1    By product

3.3.2    By application

3.3.3    By end-use

3.4    COVID-19 impact analysis

3.5    Regulatory landscape

3.5.1    U.S.

3.5.2    Europe

3.6    Patent analysis

3.7    Porter’s analysis

3.8    PESTEL analysis

Chapter 4   Competitive Landscape, 2021

4.1    Introduction

4.2    Competitive dashboard, 2021

4.3    Company matrix analysis, 2021

4.4    Competitive analysis of major market players

4.5    Competitive positioning matrix

4.6    Strategic outlook matrix

Chapter 5   Interventional Cardiology & Peripheral Vascular Devices Market, By Product

5.1    Key product trends

5.2    Interventional catheters

5.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.3    Guidewires

5.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.4    Stents

5.4.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.4.2    Bioabsorbable stents

5.4.2.1   Market estimates and forecast, 2018 - 2032 (USD Million)

5.4.3    Drug eluting stents

5.4.3.1   Market estimates and forecast, 2018 - 2032 (USD Million)

5.4.4    Bare metal stents

5.4.4.1   Market estimates and forecast, 2018 - 2032 (USD Million)

5.4.5    Others

5.4.5.1   Market estimates and forecast, 2018 - 2032 (USD Million)

5.5    PTCA balloons

5.5.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.6    Atherectomy devices

5.6.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.7    Chronic total occlusion devices

5.7.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.8    Synthetic surgical grafts

5.8.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.9    Embolic protection devices

5.9.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.10    Inferior vena cava filters

5.10.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.11    Others

5.11.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6   Interventional Cardiology & Peripheral Vascular Devices Market, By Application

6.1    Key application trends

6.2    Congenital heart defect correction

6.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.3    Coronary thrombectomy

6.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.4    Angioplasty

6.4.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.5    Valvuloplasty

6.5.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.6    Percutaneous valve repair

6.6.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.7    Others

6.7.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7   Interventional Cardiology & Peripheral Vascular Devices Market, By End-use

7.1    Key end-use trends

7.2    Hospital

7.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

7.3    Ambulatory surgical centers

7.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

7.4    Others

7.4.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8   Interventional Cardiology & Peripheral Vascular Devices Market Market, By Region

8.1    Key regional trends

8.2    North America

8.2.1    U.S.

8.2.2    Canada

8.3    Europe

8.3.1    Germany

8.3.2    UK

8.3.3    France

8.3.4    Italy

8.3.5    Spain

8.3.6    Poland

8.3.7    The Netherlands

8.3.8    Sweden

8.3.9    Austria

8.3.10    Denmark

8.4    Asia Pacific

8.4.1    China

8.4.2    Japan

8.4.3    India

8.4.4    South Korea

8.4.5    Australia

8.4.6    Thailand

8.4.7    Singapore

8.4.8    Indonesia

8.5    Latin America

8.5.1    Brazil

8.5.2    Mexico

8.5.3    Argentina

8.5.4    Chile

8.5.5    Colombia

8.5.6    Peru

8.6    Middle East & Africa

8.6.1    Saudi Arabia

8.6.2    South Africa

8.6.3    UAE

8.6.4    Israel

8.6.5    Egypt

Chapter 9   Company Profiles

9.1    Abbott Laboratories

9.2    Medtronic Plc

9.3    B. Braun Melsungen AG

9.4    Boston Scientific Corporation

9.5    AngioDynamics

9.6    Biotronik SE & Co. KG

9.7    Cook Medical

9.8    W.L. Gore & Associates, Inc.

9.9    Teleflex Inc.

9.10    Cardinal Health

9.11    C. R. Bard (Becton Dickinson and Company)